Expression of syndecan-1 in inflammatory bowel disease and a possible mechanism of heparin therapy

Citation
R. Day et al., Expression of syndecan-1 in inflammatory bowel disease and a possible mechanism of heparin therapy, DIG DIS SCI, 44(12), 1999, pp. 2508-2515
Citations number
40
Categorie Soggetti
Gastroenerology and Hepatology","da verificare
Journal title
DIGESTIVE DISEASES AND SCIENCES
ISSN journal
01632116 → ACNP
Volume
44
Issue
12
Year of publication
1999
Pages
2508 - 2515
Database
ISI
SICI code
0163-2116(199912)44:12<2508:EOSIIB>2.0.ZU;2-U
Abstract
Heparin apparently aids healing in ulcerative colitis although its mechanis m of action is unknown. The purpose of this study was to investigate the hy pothesis that heparin functions as a coreceptor molecule for basic fibrobla st growth factor, a role usually performed by heparan sulfate chains on syn decan-1, A marked reduction of syndecan-1 immunostaining was found in repar ative epithelium from inflammatory bowel disease patients. Removal of hepar an sulfate on gastrointestinal epithelial cells in vitro reduced the prolif erative response to basic fibroblast growth factor. The response to basic f ibroblast growth factor was completely restored by the addition of heparin, Loss of syndecan-1 expression occurs in the regenerative mucosa in inflamm atory bowel disease. Although this may facilitate tissue motility, its loss probably adversely affects the ability of cells to bind basic fibroblast g rowth factor. The present data show that heparin may substitute the loss of functional activity of syndecan-1 in the binding of basic fibroblast growt h factor.